Peter Joel Hosein, Michael Rothe, Elizabeth Garrett-Mayer, Ari David Baron, Timothy Lewis Cannon, Evan P. Pisick, Evthokia Hobbs, Kathryn Finch Mileham, Matthew Joseph Tinguely, Marina Frimer, Philip Jordan Gold, Kelsey Klute, Sherise C. Rogers, Vaibhav Sahai, Davendra Sohal, Sachdev P. Thomas, Jerome Dallas Winegarden, Abby Gregory, Susan Halabi, Richard L. Schilsky. "Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.715